The latest news for pharma industry insiders.
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine
Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Health Plan Design Challenges and the Impact of HSAs on Healthcare Use
Paul Fronstin, director of Health Benefits Research at EBRI, spoke with MHE about the challenges employers face in incentivizing high-value healthcare while managing costs.
Trump’s Trade Chief Advocates ‘Strategic Decoupling’ From China
President-elect Donald Trump’s pick for the top trade position sees China as a “generational challenge” to the US and has advocated for a strategic decoupling from the country.
Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
Natera, Inc. announced that its Prospera Lung test has met coverage requirements from the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostics Services (MolDX) Program for single lung transplant (SLT) recipients. This coverage applies to SLT patients in the surveillance setting.
In a recent interview with Pharmaceutical Executive, our VP of Ad Partnerships and Strategy, Theodore Sweetser, shares how the rise of data privacy regulations and the decline of third-party cookies has healthcare advertisers facing new challenges. 🍪
Ted highlights how real-world data can help by combining advanced analytics and privacy-compliant targeting, allowing healthcare advertisers to deliver more effective, patient-centric campaigns without relying on traditional cookie-based tracking.
Watch Ted’s interview here and learn how PurpleLab is helping advertisers stay ahead of the curve in a privacy-first world.
🔗https://lnkd.in/eBseFwZf
#HealthcareAdvertising #DataPrivacy #RealWorldData #AdvertisingInnovation #DigitalMarketing #PrivacyCompliance #RWD #HealthcareMarketing
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs